Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
eNq1mFFv2jAQx9/5FFHeSQKUQqdAtbF2Q2pVRos27QU5yVHMgp2ebaD79DOEbnRy1NbUEg8hTv538f3988nx+WaZeytAQTnr+Y0g8j1gKc8ou+/5k7vLetc/79fiBVmRg8c6QRQ0mr6X5kSInr8dDRIgTAQ/rq8+g34f0O/XvJgnC0jls+eUpHnwlYj5NSm2z3jxitPMW4Kc86znF0ru7nqxkKiz6K85/hIFSSEO93cORxfTk8P7cbgVe4WqEoBXhN0bRYFZaaYKEZgcEAn3HB+N0rN02ux2TqOoaxWCijEIrjCFEZHzEfIVzSAzRyK5AKsgs3V2C7jKQW6DGMXDRboUVuJkQTZjeBiak/6oRwdyI+tRvdE57TTaUXQWtdqRVSg8mCqzefRHhMW01Wo19S8EFtJlgmpFU1Kn+kJSRhPLOo04SpI7qhAVg+decxQH4eFFJ2RUFDl5DBaisJ0qgkQPA2oiuPuQ7RfcoWZUrufsP32m8jx8Y9aTPUEcZbwF1IArJitAcjm2nYgBZxI21RW1Y5/c7L1IQbyf7G/OzNwfqSSnqS3eNIAUCDkZD6vp5goMn4iACbojw3fKMr4W70+cwwo7yr7YQdMoWmDWmDbPuqeNdtt6Qf3UdqrYeS4U8gJCzSIqjkHMkM34sXDRDjVLPfnTiTV3LRFPSQ4VTVHdkjnak089nDPXu1tR5YBR9MvFna1VvinAx9vdX6M0zXp/i2wHZBeU18asTPztNi9X+yva5ZOu5SQoNMNkLmUhPoTher0O5kTUBdGTFczQKfgP9l13jbuTzb1sdkp4Oko9KXfFt1XLdvG9tP0f29Lu39+3zsYYEhUcUYuS085oOrx4f0D/62edpT16BhR3YXa9J5GUM1d9kErMTdBRW4KuK7tEDYib2YxWnKdU+jIOy7Ocfi0Ot+c4/dofbmv7Fw==
7KGKWKaxsBJCxyNZ
Listen
